Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-361
Closed -$52.8K 1024
2025
Q3
$52.8K Hold
361
0.01% 303
2025
Q2
$56.3K Hold
361
0.01% 294
2025
Q1
$59.4K Hold
361
0.01% 278
2024
Q4
$58.8K Buy
361
+342
+1,800% +$61.2K 0.01% 271
2024
Q3
$3.71K Sell
19
-72
-79% -$13.3K ﹤0.01% 793
2024
Q2
$15.8K Hold
91
﹤0.01% 508
2024
Q1
$15.4K Buy
91
+72
+379% +$13.5K ﹤0.01% 522
2023
Q4
$3.75K Buy
+19
New +$3.36K ﹤0.01% 728
2022
Q1
Sell
-5
Closed -$1K 848
2021
Q4
$1K Hold
5
﹤0.01% 783
2021
Q3
$1K Hold
5
﹤0.01% 788
2021
Q2
$1K Hold
5
﹤0.01% 780
2021
Q1
$1K Hold
5
﹤0.01% 740
2020
Q4
$1K Hold
5
﹤0.01% 673
2020
Q3
$1K Hold
5
﹤0.01% 655
2020
Q2
$1K Sell
5
-39
-89% -$5.09K ﹤0.01% 655
2020
Q1
$5K Buy
+44
New +$5.79K ﹤0.01% 453

Other funds holding ZTS

McIlrath & Eck's ZTS Position: Q4 2025 in Review

McIlrath & Eck sold out of Zoetis (ZTS) in Q4 2025, closing a stake of 361 shares — an estimated $52.8K sold.

McIlrath & Eck first reported a position in ZTS in Q1 2020 and held it in 16 quarters. The position peaked at $59.4K in Q1 2025. 1,682 funds tracked by Wall St. Rank hold ZTS as of Q4 2025.

  • McIlrath & Eck reported no remaining Zoetis position as of Q4 2025 after selling out during the quarter.
  • McIlrath & Eck sold 361 Zoetis shares in Q4 2025, an estimated $52.8K.
  • McIlrath & Eck first reported a position in Zoetis in Q1 2020 and held it in 16 quarters.
  • McIlrath & Eck's Zoetis position peaked at $59.4K in Q1 2025.
  • 1,682 funds tracked by Wall St. Rank held Zoetis as of Q4 2025.

Based on McIlrath & Eck's 13F filing for Q4 2025, filed 3 Feb 2026.